BioMarin Pharmaceutical (BMRN) ROE US GAAP (year values) |
||||||||
2021 | 2022 | 2022 | 2023 | LTM ? | ||||
ROE, % | ? | -1.50% | 0.00% | 3.08% | 3.08% | 3.39% | 1 965% | |
Changes by years, y/y, % | -22pp | +2pp | 0pp | +0pp |
BioMarin Pharmaceutical. ROE, %
BioMarin Pharmaceutical. ROE, changes, pp
BioMarin Pharmaceutical (BMRN) ROE US GAAP (quarter values) |
||||||||
2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q3 | LTM ? | |||
ROE, % | ? | 4.05% | 4.05% | 4.85% | 1.96% | 5.95% | 1 965% | |
Changes by years, y/y, % | +3pp | +3pp | +3pp | -1pp | +3pp | |||
Changes by quarters, q/q, % | +1pp | 0pp | +1pp | -3pp | +4pp |